Gilead Sciences, Inc. GILD
150.93
1.24
0.83%
as of 25 Sep
- Market cap
- $183.2B
- P/E
- 0.0×
Follow GILD
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Gilead Sciences, Inc. (GILD) Operating margin
Gilead Sciences, Inc.'s operating margin over the twelve months to 30 June 2026 was −8.20%, down 42.2 percentage points from fiscal 2025 (34.0%). Over the past ten years it has ranged from 5.78% (fiscal 2024) to 68.0% (fiscal 2015); the current reading is higher than 55% of that period. That is below the Drug Manufacturers General industry median of 18.9% and below the Healthcare sector median of 0.00%.
Operating margin, annual
Annual
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 34.0% | 28.26 |
| FY2024 | 5.78% | (22.27) |
| FY2023 | 28.1% | 1.18 |
| FY2022 | 26.9% | (9.45) |
| FY2021 | 36.3% | 19.83 |
| FY2020 | 16.5% | (2.61) |
| FY2019 | 19.1% | (17.96) |
| FY2018 | 37.1% | (17.04) |
| FY2017 | 54.1% | (3.92) |
| FY2016 | 58.0% | (9.98) |
Quarterly
| Period | Operating margin | Change (points) |
|---|---|---|
| Jun 2026 | −133.2% | (170.35) |
| Mar 2026 | 37.1% | 12.11 |
| Dec 2025 | 25.0% | (17.79) |
| Sep 2025 | 42.8% | 7.89 |
| 42 more quarters | Free account |
Against its own ten years
Low 5.78%
High 68.0%
Ten-year median
34.0%
Current reading's percentile
55
Operating margin against peers
| Company | Operating margin |
|---|---|
| NVO Novo Nordisk A/S compare | 43.4% |
| NVS Novartis AG compare | 30.2% |
| AMGN Amgen Inc. compare | 30.0% |
| BMY Bristol Myers Squibb Company compare | 24.2% |
| AZN AstraZeneca PLC compare | 22.8% |
| PFE Pfizer Inc. compare | 21.7% |
| GSK GSK PLC Sponsored ADR compare | 19.6% |
| SNY Sanofi compare | 18.2% |
| GILD Gilead Sciences, Inc. | −8.20% |
| Drug Manufacturers General industry median | 18.9% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on GILD
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement